Ftse Mib
35.138,61
0,98%
DAX
20.271,33
0,67%
S&P 500
5.854,53
0,31%
NASDAQ
19.128,32
0,21%
Bitcoin
96.892,15
2,52%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Zura Bio Ltd (ZURA) Zura Bio Ltd (ZURA) Notizie

Zura Bio Ltd

ZURA
1,935
-0,055 (-2,76%)
Ultimo aggiornamento: 20:17:52
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
31/12/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202412:45EDGAR2Form 8-K - Current report
23/12/202412:30BWZura Bio Launches Global Phase 2 TibuSURE Study to Evaluate..
11/12/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202412:45EDGAR2Form 8-K - Current report
25/11/202412:30BWZura Bio to Present at the Piper Sandler 36th Annual..
14/11/202422:47EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
14/11/202422:45EDGAR2Form 8-K - Current report
14/11/202422:30BWZura Bio Announces Submission of Protocol to U.S. Food and..
07/11/202413:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202412:51EDGAR2Form 8-K - Current report
07/11/202412:30BWZura Bio Reports Third Quarter 2024 Financial Results and..
30/10/202411:50EDGAR2Form 8-K - Current report
30/10/202411:30BWZura Bio to Participate in Two Upcoming Investor Conferences..
29/10/202421:15EDGAR2Form 8-K - Current report
18/10/202422:15EDGAR2Form 8-K - Current report
11/9/202422:57EDGAR2Form S-3/A - Registration statement under Securities Act of..
11/9/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
09/9/202422:22EDGAR2Form 8-K - Current report
03/9/202412:00BWZura Bio to Present at Three Upcoming Investor Conferences..
21/8/202422:01EDGAR2Form 8-K - Current report
13/8/202415:21BWZura Bio Reports Second Quarter 2024 Financial Results and..
12/8/202422:46EDGAR2Form 425 - Prospectuses and communications, business..
12/8/202422:42EDGAR2Form 8-K - Current report
12/8/202422:05BWZura Bio Completes Exchange Offer and Consent Solicitation..
09/8/202423:26EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
09/8/202423:05EDGAR2Form 425 - Prospectuses and communications, business..
09/8/202422:33EDGAR2Form 8-K - Current report
09/8/202422:05BWZura Bio Announces Expiration and Results of Exchange Offer..
12/7/202412:10BWZura Bio Commences Warrant Exchange Offer and Consent..
14/6/202412:00BWZura Bio Presents Data for the Tibulizumab (ZB-106) Program..
06/6/202412:00BWZura Bio Forms Scientific Advisory Board with Prominent..
03/6/202412:00BWZura Bio to Present Data Exploring the Expanded Potential of..
29/5/202412:00BWZura Bio Announces Participation in June Investor..
09/5/202412:00BWZura Bio Reports First Quarter 2024 Financial Results and..
18/4/202415:22BWZura Bio Announces Oversubscribed $112.5 Million Private..
08/4/202412:00BWZura Bio Announces Robert Lisicki as CEO and Director
28/3/202411:00BWZura Bio Reports Full Year 2023 Financial Results, Business..
04/3/202412:00BWZura Bio Announces Participation at March Conferences
23/2/202422:30EDGAR2Form 8-K - Current report
14/2/202415:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202412:00BWZura Bio Announces Participation at February Investor..
26/1/202417:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 2,03 Min: 1,91 Max: 2,04
Chiusura: 1,99

La tua Cronologia

NASDAQ
ZURA
Zura Bio
BIT
S28161
Societe Generale Effekten
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network